Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"

被引：0

作者：

Strawn, Jeffrey R. ^{[1
,2
]}

Mills, Jeffrey A. ^{[1
]}

机构：

[1] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA

[2] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45219 USA

来源：

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2024年

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页数：2

共 50 条

[1] Response to Ploderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"
Strawn, Jeffrey R.
Mills, Jeffrey A.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, 34 (02) : 106 - 107
[2] A MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ESCITALOPRAM IN CHILDREN AND ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER
Strawn, Jeffrey Robert
Moldauer, Leslie
Hahn, Rebekah D.
Wise, Alexandria
Bertzos, Kristina
Eisenberg, Beth
Greenberg, Edward F.
Liu, Chengcheng
Gopalkrishnan, Mallika
Mcvoy, Molly
Knutson, James A.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S185 - S185
[3] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder
Strawn, Jeffrey R.
Moldauer, Leslie
Hahn, Rebekah D.
Wise, Alexandria
Bertzos, Kristina
Eisenberg, Beth
Greenberg, Edward
Liu, Chengcheng
Gopalkrishnan, Mallika
McVoy, Molly
Knutson, James A.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (03) : 91 - 100
[4] Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al.-Concerning Harm-Benefit Ratio in a Recent Trial About Escitalopram for Generalized Anxiety Disorder
Ploederl, Martin
Horowitz, Mark A.
Hengartner, Michael P.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (07) : 295 - 296
[5] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder (vol 33, pg 91, 2023)
Strawn
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (05) : 200 - 200
[6] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study
Strawn, Jeffrey R.
Mills, Jeffrey A.
Schroeder, Heidi
Mossman, Sarah A.
Varney, Sara T.
Ramsey, Laura B.
Poweleit, Ethan A.
Desta, Zeruesenay
Cecil, Kim
DelBello, Melissa P.
JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
[7] ESCITALOPRAM RESPONSE IS ASSOCIATED WITH CHANGES IN ENDOCANNABINOID SIGNALING IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Strawn, Jeffrey
Mills, Jeffrey
Schroeder, Heidi
Marusak, Hilary
NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 311 - 312
[8] A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder
Wagner, KD
Berard, R
Stein, MB
Wetherhold, E
Carpenter, DJ
Perera, P
Gee, M
Davy, K
Machin, A
ARCHIVES OF GENERAL PSYCHIATRY, 2004, 61 (11) : 1153 - 1162
[9] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study With Pharmacogenomic and Pharmacokinetic Measures
Strawn, Jeffrey
Mills, Jeffrey
Schroeder, Heidi
Mossman, Sarah
Varney, Sara
Ramsey, Laura
Poweleit, Ethan
Desta, Zeruesenay
Cecil, Kim
DelBello, Melissa
NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 88 - 89
[10] BASELINE EXECUTIVE FUNCTION AND ITS RELATIONSHIP TO ESCITALOPRAM RESPONSE IN ADOLESCENTS WITH ANXIETY: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Baumel, William Thomas
Mills, Jeffrey A.
Schroeder, Heidi K.
Specht, Ashley M.
Rothenberg, Richard
Peris, Tara S.
Strawn, Jeffrey Robert
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S185 - S185

← 1 2 3 4 5 →